Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
REV-ERB agonist
synthetic compound |
| gptkbp:actsOn |
agonist
|
| gptkbp:administeredBy |
animal studies
|
| gptkbp:CASNumber |
1379686-30-2
|
| gptkbp:chemicalFormula |
C23H31ClN4O3S
|
| gptkbp:developedBy |
gptkb:Scripps_Research_Institute
|
| https://www.w3.org/2000/01/rdf-schema#label |
SR9011
|
| gptkbp:IUPACName |
(E)-N-(4-chlorophenyl)-3-((2,2-dimethyl-1,3-dioxolan-4-yl)methylamino)-4-(methylthio)but-2-enamide
|
| gptkbp:legalStatus |
not approved for human use
|
| gptkbp:molecularWeight |
495.04 g/mol
|
| gptkbp:studiedBy |
obesity
metabolic disorders circadian rhythm muscle endurance |
| gptkbp:target |
gptkb:REV-ERBα
gptkb:REV-ERBβ |
| gptkbp:bfsParent |
gptkb:SR_90003
|
| gptkbp:bfsLayer |
8
|